Bristol-Myers Squibb Says FDA-Approved ORENCIA Is Available For Adults With Moderate To Severe Rheumatoid Arthritis
July 20, 2016 at 08:14 AM EDT
Bristol-Myers Squibb Company (NYSE: BMY) disclosed Wednesday the commercial launch of the FDA-approved ORENCIA ClickJectTM ...